Barclays lowered the firm’s price target on Universal Health (UHS) to $262 from $263 and keeps an Overweight rating on the shares. The firm adjusted targets in the healthcare facilities and managed care group as part of a preview of 2026 outlooks.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target lowered to $245 from $251 at TD Cowen
- Wells Fargo downgrades Universal Health to Equal Weight, lowers target to $235
- Universal Health downgraded to Equal Weight from Overweight at Wells Fargo
- Universal Health Extends CEO Marc Miller’s Employment Term
- Hospital stocks lower after Republicans propose Medicare funding cut